Journal article
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study
Josep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, Yoshinobu Onuma, Vasim Farooq, Leif Thuesen, Dougal McClean, Jacques Koolen, John A Ormiston, Stefan Windecker, Robert Whitbourn, Dariusz Dudek, Cecile Dorange, Susan Veldhof, Richard Rapoza, Evelyn Regar, Hector M Garcia-Garcia, Patrick W Serruys
EuroIntervention | EUROPA EDITION | Published : 2012
DOI: 10.4244/EIJV8I2A35
Grants
Funding Acknowledgements
The ABSORB Cohort B trial has been supported by Abbott Vascular (Santa Clara, CA, USA).